Skip to : [Content] [Navigation]
 

Originally Published MDDI October 2002

INTERNATIONAL AFFAIRS

General Recommendations to Carry out Effective Informed Consent for Clinical Trials in Japan
  • Explain the purpose of the study clearly and simply.
  • Distinguish investigational treatment from standard care.
  • Avoid overstating the potential benefit of the investigational treatment.
  • Focus on physical and nonphysical risks associated with the investigational treatment as a whole.
  • Estimate broadly the likelihood of the risks associated with the investigational treatment.
  • Provide supplementary documents that are easy to read and culturally sensitive, and continue to provide these materials throughout the lifetime of the study.

Copyright ©2002 Medical Device & Diagnostic Industry